You’ve heard of CBD derived from the cannabis plant. But did you know non-cannabis derived CBD existed? You do now.
CBD, or cannabidiol, is the non-intoxicating wellness cannabinoid possessing the healing potential not seen with anything else in the natural world. Or the actual world, for that matter. The fact that CBD contains multifaceted properties that rid pain and anxiety, reduce inflammation, treat skin conditions, aid in focus, mood improvement, gut health, and so much more, is still mind-boggling to us.
Researchers are continuing to unleash more positive results from the impressive compound, including a discovery of CBD derived from a non-cannabis plant.
The Skinny on Non-Cannabis Derived CBD
Dr. Bomi Joseph, director of Peak Health, a San Francisco holistic medicine center, has discovered a kyria brand humulus plant that is a variety of hop (the plant beer is brewed with), that can reliably produce CBD. This hop plant cross-pollinates with wild cannabis plants that grow nearby, naturally endowing it with a high concentration of CBD.
From the hop plant, Joseph has created a product using humulus plant derived CBD, a form that’s been dubbed ImmunAg. It is the only major source of CBD from a non-cannabis plant, and like hemp-derived CBD is a completely natural herbal complex that helps support the Endocannabinoid System (the regulatory system in the human body responsible for promoting and maintaining homeostasis).
Typically, hops do not produce CBD, which is why this certain crop of the humulus yunnanensis plant, which had been cross-pollinated with cannabis, was such an intriguing discovery.
It’s important to note that this specific hop plant is not the same thing as the hops we know, more formally known as humulus lupulus, but a variety of humulus yunnanensis, one of three species of the humulus genus. One significant mark in the pro column for humulus derived CBD is that it does not have the same legal barriers that cannabis faces.
Developing the first non-cannabis plant with CBD
When one of Joseph’s colleagues at Peak Health found a reference to the kyria brand humulus plant at a symposium given by India’s Central Food Technological Research Institute, their analysis of the plant discovered traces of cannabinoids, which was when Joseph knew he needed to check things out for himself. So he traveled to India, where he originates.
After looking at thousands of samples when he got there, he found one with CBD in it.
Joseph stated in an interview, “Then it was just a matter of grunt work and effort,” regarding cross-breeding the plants until he had created a dependable, high-CBD concentration variety.
Joseph and his team have since developed a hop plant that can reliably produce CBD, and has begun sharing the information – and selling his new products – across the country in partnership with Medical Marijuana Inc.
CEO of Medical Marijuana Inc., Stuart Titus, stated in the same interview that, “This is certainly going to help change the dialogue for not only many parents whose children have epilepsy, but various other world markets.”
Now, Titus, Joseph and their teams are expanding their hop-based CBD oil internationally so patients in countries with the toughest cannabis laws can gain the benefits of CBD.